These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19349405)

  • 1. An elderly man with rheumatoid arthritis and dyspnea.
    Nesheiwat JP; Dillon K; McGlothan K; Zaman M; Carbone LD
    Chest; 2009 Apr; 135(4):1090-1093. PubMed ID: 19349405
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
    Ochi S; Harigai M; Mizoguchi F; Iwai H; Hagiyama H; Oka T; Miyasaka N
    Mod Rheumatol; 2006; 16(5):316-20. PubMed ID: 17039315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.
    Keng LT; Lin MW; Huang HN; Chung KP
    Medicine (Baltimore); 2016 Jun; 95(26):e4044. PubMed ID: 27368035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.
    Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA
    Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomide.
    Spanakis EK; Katsikas GA; Sidiropoulos PI; Kritikos HD
    Clin Exp Rheumatol; 2008; 26(2):382. PubMed ID: 18565269
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient.
    Ricci M; Rossi P; De Marco G; Varisco V; Marchesoni A
    Rheumatology (Oxford); 2010 Oct; 49(10):2001. PubMed ID: 20601656
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of multiple pulmonary nodules during treatment with leflunomide.
    Yoshikawa GT; Dias GA; Fujihara S; Silva LF; Cruz Lde B; Fuzii HT; Koyama RV
    J Bras Pneumol; 2015; 41(3):281-4. PubMed ID: 26176527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
    Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
    Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
    [No Abstract]   [Full Text] [Related]  

  • 9. Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis.
    Kemp E; Nielsen H; Petersen LJ; Gam AN; Dahlager J; Horn T; Larsen S; Olsen S
    Clin Nephrol; 2001 Jan; 55(1):87-8. PubMed ID: 11200876
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary adverse events with leflunomide--myth or reality?
    Balakrishnan C; Dasgupta B
    Rheumatology (Oxford); 2007 Feb; 46(2):372; author reply 372-3. PubMed ID: 17158807
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis.
    Grabar PB; Rozman B; Logar D; Praprotnik S; Dolzan V
    Ann Rheum Dis; 2009 Aug; 68(8):1367-8. PubMed ID: 19605743
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral neuropathy in patients on leflunomide.
    Bharadwaj A; Haroon N
    Rheumatology (Oxford); 2004 Jul; 43(7):934. PubMed ID: 15213340
    [No Abstract]   [Full Text] [Related]  

  • 14. Leflunomide (Arava)-induced cystoid macular oedema.
    Barak A; Morse LS; Schwab I
    Rheumatology (Oxford); 2004 Feb; 43(2):246-8. PubMed ID: 14739469
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe aplastic anaemia following leflunomide therapy.
    Wüsthof M; Smirnova A; Bacher U; Kröger N; Zander AR; Schuch G; Bokemeyer C
    Rheumatology (Oxford); 2010 May; 49(5):1016-7. PubMed ID: 20032226
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancytopenia associated with leflunomide and methotrexate.
    Hill RL; Topliss DJ; Purcell PM
    Ann Pharmacother; 2003 Jan; 37(1):149. PubMed ID: 12503951
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on 'Drug-related pulmonary problems in patients with rheumatoid arthritis'.
    Yazici Y; Yazici H
    Rheumatology (Oxford); 2007 Feb; 46(2):371-2; author reply 372-3. PubMed ID: 17158808
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug.
    Wardwell NR; Miller R; Ware LB
    Respirology; 2006 Sep; 11(5):663-5. PubMed ID: 16916345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
    Bingham SJ; Buch MH; Kerr MA; Emery P; Valadäo Barcelos AT
    Arthritis Rheum; 2004 Dec; 50(12):4072-3. PubMed ID: 15593202
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide-induced subacute cutaneous lupus erythematosus.
    Goëb V; Berthelot JM; Joly P; Mejjad O; de Quatrebarbes J; Reynaud-Hautin C; Vittecoq O; Le Loët X
    Rheumatology (Oxford); 2005 Jun; 44(6):823-4. PubMed ID: 15757964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.